₹ 113.17
5.38 (4.99%)
NSE
P
Par Drugs & Chemical
₹ 113.17
NSE
PAR Financials Summary
Par Drugs & Chemical revenue decreased 14.91% quarter-on-quarter to ₹27 Cr in Sep 2026, while net profit decreased 44.68% quarter-on-quarter to ₹3 Cr. Compared to the same quarter last year, revenue is down 5.84% and net profit is down 36.59%. EPS for the quarter stood at ₹2.14, decreased from ₹3.83 in the previous quarter and down from ₹3.36 a year ago.
Par Drugs & Chemical Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of PAR Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
PAR Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






